+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vision Care Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 316 Pages
  • October 2022
  • Region: Global
  • GlobalData
  • ID: 5693528
The publisher's Medical Devices sector report, “Vision Care Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Vision Care pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vision care category covers surgical instruments and therapeutic accessories in ophthalmology to enhance patient's vision outcome. These include contact lens cleaning and disinfecting solutions, contact lenses, spectacle lenses and microkeratomes.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vision Care under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vision Care and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vision Care under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Vision Care Overview
3 Products under Development
3.1 Vision Care - Pipeline Products by Stage of Development
3.2 Vision Care - Pipeline Products by Segment
3.3 Vision Care - Pipeline Products by Territory
3.4 Vision Care - Pipeline Products by Regulatory Path
3.5 Vision Care - Pipeline Products by Estimated Approval Date
3.6 Vision Care - Ongoing Clinical Trials
4 Vision Care - Pipeline Products under Development by Companies
4.1 Vision Care Companies - Pipeline Products by Stage of Development
4.2 Vision Care - Pipeline Products by Stage of Development
5 Vision Care Companies and Product Overview6 Vision Care- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Vision Care - Pipeline Products by Stage of Development
  • Vision Care - Pipeline Products by Segment
  • Vision Care - Pipeline Products by Territory
  • Vision Care - Pipeline Products by Regulatory Path
  • Vision Care - Pipeline Products by Estimated Approval Date
  • Vision Care - Ongoing Clinical Trials
  • Vision Care Companies - Pipeline Products by Stage of Development
  • Vision Care - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Vision Care - Pipeline Products by Stage of Development
  • Vision Care - Pipeline Products by Segment
  • Vision Care - Pipeline Products by Territory
  • Vision Care - Pipeline Products by Regulatory Path
  • Vision Care - Pipeline Products by Estimated Approval Date
  • Vision Care - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 2C Tech Corporation Inc
  • Advanced Medical Electronics Corp
  • Adventus Technology Inc
  • Aeon Astron Corporation
  • Ai Kangte Medical Technology Co Ltd
  • Alcon Inc
  • Alcon Laboratories Inc
  • Allotex Inc
  • Apeliotus Ophthalmics (Inactive)
  • Axcelon Biopolymers Corp
  • Azalea Vision
  • Bar-Ilan University
  • Bausch & Lomb Inc
  • Biel Glasses SL
  • Bionic Sight LLC
  • Bionic Vision Australia
  • Bionic Vision Technologies Pty Ltd
  • Bionode LLC
  • Body Organ Biomedical Corp
  • Cellico
  • Clerio Vision Inc
  • Cornea Biosciences
  • Corneat Vision Ltd
  • DeepOptics
  • eSight Corp
  • EssilorLuxottica SA
  • Euclid Systems Corp
  • e-Vision Medical Devices, Inc.
  • Eyenovations
  • EyeYon Medical
  • Fitlens Ltd
  • Florida International University
  • Forschungszentrum Julich GmbH
  • Hoya Vision Care NA
  • iBionics Inc
  • iCheck LLC
  • Illinois Institute of Technology
  • i-Lumen Scientific Inc
  • Imperial College London
  • Industrial Science & Technology Network Inc
  • Innovega Inc
  • Institute of Photonic Sciences
  • International Center for Materials Nanoarchitectonics
  • iSTAR Medical SA
  • Johns Hopkins University
  • Johnson & Johnson Vision Care Inc
  • Khalifa University
  • Kubota Vision Inc
  • Laclaree Vision
  • Lentechs LLC
  • Linkocare Life Sciences AB
  • Lipocoat BV
  • Lynthera Corp
  • MAG Optics Inc
  • Massachusetts Eye and Ear Infirmary
  • McGill University
  • McGowan Institute for Regenerative Medicine
  • Mercy Health Research
  • Meta Biomed Co Ltd
  • Mojo Vision Inc
  • Monash University
  • Nano Retina, Inc.
  • NanoScope Technologies LLC
  • National University of Singapore
  • Novartis AG
  • Nunaps Inc
  • Ocular Dynamics, LLC
  • Ocutec Ltd
  • Ocutrx Vision Technologies LLC
  • Okayama University
  • OPIA Technologies SAS
  • OptoLight Vision Technology
  • Oxsight Ltd
  • Pandorum International Inc
  • PixelOptics Inc
  • Pixium Vision SA
  • Presbia Plc
  • Purdue University
  • Queensland University of Technology
  • Refocus Group Inc
  • RetMap Inc
  • Samsara Vision
  • Seryx Biomedical Inc
  • Shamir Optical Industry Ltd
  • Shanghai Haohai Biological Technology Co Ltd
  • Shenzhen Sibionics Technology Co Ltd
  • SightGlass Vision Inc
  • Spanish National Research Council
  • Stanford University
  • SynergEyes Inc
  • TECLens LLC
  • Tel Aviv University
  • Terasaki Institute for Biomedical Innovation
  • The University of New South Wales press Limited
  • The Wilmer Eye Institute at Johns Hopkins
  • Tsubota Laboratory Inc
  • U.S. Army Medical Research and Development Command
  • University of California Irvine
  • University of California San Diego
  • University of Illinois at Chicago
  • University of New Hampshire
  • University of Oxford
  • University of Seville
  • University of South Florida
  • University of Tennessee
  • University of Tubingen
  • University of Valencia
  • University of Washington
  • Va-st Ltd
  • Verily Life Sciences
  • Visioneering Technologies Inc
  • VISTAKON Pharmaceuticals LLC
  • Visus Technology Inc
  • Weill Cornell Medical College